387 results
Page 3 of 20
8-K
EX-99.1
0scnxgnm8ud1
31 Jul 20
Continued Revenue Growth and Earnings Expansion on Solid Execution Across Both Segments
12:00am
8-K
EX-99.1
tjdmvuqxx6h
30 Apr 20
Double-digit Revenue Growth in Both Segments Supports High Growth in EPS
4:10pm
8-K
EX-99.1
9eg8rb5mmhmh2rr
6 Feb 20
Results of Operations and Financial Condition
4:07pm
NT 10-K
1reluik
2 Dec 19
Notice of late annual filing
9:00am
8-K
EX-99.1
6r9 zffyu
6 Nov 19
Revenue Growth at 24% Caps Off a Transformative Year of High Growth and Margin Expansion
4:11pm
S-3ASR
vx8gjkqwpj48l9p fs2
8 Aug 19
Automatic shelf registration
4:42pm
8-K
EX-99.1
emo81pei
1 Aug 19
Double-digit Year-over-Year Revenue Growth, Margin Expansion, and Reduction of Debt
4:10pm
8-K
EX-2.1
05613enlq
5 Jul 19
Entry into a Material Definitive Agreement
7:40am
8-K
EX-99.1
a3w x4x63m
29 Apr 19
Solid Revenue Growth and Profitability on Strong Life Sciences and Stable Semiconductor Performance
4:18pm
8-K
EX-99.1
av1b8
5 Feb 19
Results of Operations and Financial Condition
4:10pm